S&P 500   3,691.70 (+0.68%)
DOW   30,151.71 (+0.61%)
QQQ   305.24 (+0.32%)
AAPL   122.42 (-0.42%)
MSFT   214.03 (-0.10%)
FB   281.04 (-0.29%)
GOOGL   1,826.08 (+0.23%)
AMZN   3,168.62 (-0.57%)
TSLA   590.60 (-0.47%)
NVDA   541.56 (+1.07%)
BABA   267.34 (+0.16%)
CGC   28.66 (+0.10%)
GE   10.69 (+0.85%)
MU   73.74 (+5.49%)
AMD   93.78 (+1.59%)
T   29.55 (+1.09%)
NIO   42.86 (-5.49%)
F   9.39 (+1.95%)
ACB   11.43 (+1.69%)
BA   234.21 (-1.26%)
NFLX   498.57 (+0.21%)
GILD   61.40 (+0.89%)
DIS   152.98 (-0.17%)
S&P 500   3,691.70 (+0.68%)
DOW   30,151.71 (+0.61%)
QQQ   305.24 (+0.32%)
AAPL   122.42 (-0.42%)
MSFT   214.03 (-0.10%)
FB   281.04 (-0.29%)
GOOGL   1,826.08 (+0.23%)
AMZN   3,168.62 (-0.57%)
TSLA   590.60 (-0.47%)
NVDA   541.56 (+1.07%)
BABA   267.34 (+0.16%)
CGC   28.66 (+0.10%)
GE   10.69 (+0.85%)
MU   73.74 (+5.49%)
AMD   93.78 (+1.59%)
T   29.55 (+1.09%)
NIO   42.86 (-5.49%)
F   9.39 (+1.95%)
ACB   11.43 (+1.69%)
BA   234.21 (-1.26%)
NFLX   498.57 (+0.21%)
GILD   61.40 (+0.89%)
DIS   152.98 (-0.17%)
S&P 500   3,691.70 (+0.68%)
DOW   30,151.71 (+0.61%)
QQQ   305.24 (+0.32%)
AAPL   122.42 (-0.42%)
MSFT   214.03 (-0.10%)
FB   281.04 (-0.29%)
GOOGL   1,826.08 (+0.23%)
AMZN   3,168.62 (-0.57%)
TSLA   590.60 (-0.47%)
NVDA   541.56 (+1.07%)
BABA   267.34 (+0.16%)
CGC   28.66 (+0.10%)
GE   10.69 (+0.85%)
MU   73.74 (+5.49%)
AMD   93.78 (+1.59%)
T   29.55 (+1.09%)
NIO   42.86 (-5.49%)
F   9.39 (+1.95%)
ACB   11.43 (+1.69%)
BA   234.21 (-1.26%)
NFLX   498.57 (+0.21%)
GILD   61.40 (+0.89%)
DIS   152.98 (-0.17%)
S&P 500   3,691.70 (+0.68%)
DOW   30,151.71 (+0.61%)
QQQ   305.24 (+0.32%)
AAPL   122.42 (-0.42%)
MSFT   214.03 (-0.10%)
FB   281.04 (-0.29%)
GOOGL   1,826.08 (+0.23%)
AMZN   3,168.62 (-0.57%)
TSLA   590.60 (-0.47%)
NVDA   541.56 (+1.07%)
BABA   267.34 (+0.16%)
CGC   28.66 (+0.10%)
GE   10.69 (+0.85%)
MU   73.74 (+5.49%)
AMD   93.78 (+1.59%)
T   29.55 (+1.09%)
NIO   42.86 (-5.49%)
F   9.39 (+1.95%)
ACB   11.43 (+1.69%)
BA   234.21 (-1.26%)
NFLX   498.57 (+0.21%)
GILD   61.40 (+0.89%)
DIS   152.98 (-0.17%)
Log in
NASDAQ:CGEN

Compugen News Headlines

$12.85
+0.06 (+0.47 %)
(As of 12/4/2020 11:46 AM ET)
Add
Compare
Today's Range
$12.77
Now: $12.85
$13.25
50-Day Range
$12.20
MA: $13.61
$17.48
52-Week Range
$5.20
Now: $12.85
$19.90
Volume17,827 shs
Average Volume1.23 million shs
Market Capitalization$879.20 million
P/E RatioN/A
Dividend YieldN/A
Beta2.59

Headlines

Compugen (NASDAQ CGEN) News Headlines Today

Source:
SourceHeadline
Compugen (NASDAQ:CGEN) Rating Lowered to Hold at BidaskClubCompugen (NASDAQ:CGEN) Rating Lowered to Hold at BidaskClub
marketbeat.com - October 21 at 1:07 AM
Compugen (NASDAQ:CGEN) Upgraded at Zacks Investment ResearchCompugen (NASDAQ:CGEN) Upgraded at Zacks Investment Research
marketbeat.com - September 29 at 9:20 PM
SVB Leerink Boosts Compugen (NASDAQ:CGEN) Price Target to $19.00SVB Leerink Boosts Compugen (NASDAQ:CGEN) Price Target to $19.00
marketbeat.com - August 19 at 8:03 AM
Compugen (NASDAQ:CGEN) Trading 5.4% Higher Compugen (NASDAQ:CGEN) Trading 5.4% Higher
americanbankingnews.com - November 27 at 7:32 PM
The Middle East & Africa drug modelling software market is expected to reach US$ 487.02 million by 2027 from US$ 297.94 million in 2019 - BenzingaThe Middle East & Africa drug modelling software market is expected to reach US$ 487.02 million by 2027 from US$ 297.94 million in 2019 - Benzinga
benzinga.com - November 26 at 5:59 PM
The Middle East & Africa drug modelling software market is expected to reach US$ 487.02 million by 2027 from US$ 297.94 million in 2019 - GlobeNewswireThe Middle East & Africa drug modelling software market is expected to reach US$ 487.02 million by 2027 from US$ 297.94 million in 2019 - GlobeNewswire
globenewswire.com - November 26 at 7:58 AM
Online Retail ETF (IBUY) Hits a New 52-Week High - NasdaqOnline Retail ETF (IBUY) Hits a New 52-Week High - Nasdaq
nasdaq.com - November 25 at 2:31 PM
Compugen (NASDAQ:CGEN) Trading Down 7.1%Compugen (NASDAQ:CGEN) Trading Down 7.1%
americanbankingnews.com - November 24 at 10:40 PM
RSI Alert: Compugen (CGEN) Now Oversold - NasdaqRSI Alert: Compugen (CGEN) Now Oversold - Nasdaq
nasdaq.com - November 24 at 6:43 PM
iShares MSCI EAFE Small-Cap ETF Experiences Big Outflow - NasdaqiShares MSCI EAFE Small-Cap ETF Experiences Big Outflow - Nasdaq
nasdaq.com - November 20 at 5:46 PM
Companies Like Compugen (NASDAQ:CGEN) Can Afford To Invest In Growth - Yahoo FinanceCompanies Like Compugen (NASDAQ:CGEN) Can Afford To Invest In Growth - Yahoo Finance
finance.yahoo.com - November 11 at 1:37 PM
Companies Like Compugen (NASDAQ:CGEN) Can Afford To Invest In GrowthCompanies Like Compugen (NASDAQ:CGEN) Can Afford To Invest In Growth
finance.yahoo.com - November 11 at 8:36 AM
Compugen to Present at Upcoming Investor Conferences - Yahoo FinanceCompugen to Present at Upcoming Investor Conferences - Yahoo Finance
finance.yahoo.com - November 10 at 10:03 AM
Compugen: Speculative Play For Immuno-Oncology ExposureCompugen: Speculative Play For Immuno-Oncology Exposure
seekingalpha.com - November 7 at 12:57 PM
Compugen: 3Q Earnings Snapshot - Yahoo FinanceCompugen: 3Q Earnings Snapshot - Yahoo Finance
finance.yahoo.com - November 7 at 12:47 AM
Compugen Ltd. (CGEN) CEO Anat Cohen-Dayag on Q3 2020 Results - Earnings Call Transcript - Seeking AlphaCompugen Ltd. (CGEN) CEO Anat Cohen-Dayag on Q3 2020 Results - Earnings Call Transcript - Seeking Alpha
seekingalpha.com - November 7 at 12:47 AM
Compugen Q3 Earnings PreviewCompugen Q3 Earnings Preview
seekingalpha.com - November 6 at 7:46 PM
Compugen Ltd. (CGEN) Q3 2020 Earnings Call Transcript - Motley FoolCompugen Ltd. (CGEN) Q3 2020 Earnings Call Transcript - Motley Fool
fool.com - November 5 at 10:58 PM
Compugen Ltd. (CGEN) Q3 2020 Earnings Call TranscriptCompugen Ltd. (CGEN) Q3 2020 Earnings Call Transcript
finance.yahoo.com - November 5 at 10:58 PM
Compugen Reports Third Quarter 2020 Results English English - PRNewswireCompugen Reports Third Quarter 2020 Results English English - PRNewswire
prnewswire.com - November 5 at 7:56 AM
Compugen Reports Third Quarter 2020 ResultsCompugen Reports Third Quarter 2020 Results
finance.yahoo.com - November 5 at 7:56 AM
Compugen Further Expands Patent Portfolio for TIGIT Inhibitor COM902 with Composition of Matter Patent in China - PRNewswireCompugen Further Expands Patent Portfolio for TIGIT Inhibitor COM902 with Composition of Matter Patent in China - PRNewswire
prnewswire.com - November 2 at 8:58 AM
Compugen Further Expands Patent Portfolio for TIGIT Inhibitor COM902 with Composition of Matter Patent in ChinaCompugen Further Expands Patent Portfolio for TIGIT Inhibitor COM902 with Composition of Matter Patent in China
finance.yahoo.com - November 2 at 8:58 AM
Whats in Store for ADMA Biologics (ADMA) Q3 Earnings? - NasdaqWhat's in Store for ADMA Biologics' (ADMA) Q3 Earnings? - Nasdaq
nasdaq.com - October 29 at 12:19 PM
Compugen Presents New Research Data Further Supporting PVRIG as a Potentially Promising Target for Cancer Immunotherapy - PRNewswireCompugen Presents New Research Data Further Supporting PVRIG as a Potentially Promising Target for Cancer Immunotherapy - PRNewswire
prnewswire.com - October 27 at 9:35 AM
Compugen to Release Third Quarter 2020 Results on Thursday, November 5, 2020 - Yahoo FinanceCompugen to Release Third Quarter 2020 Results on Thursday, November 5, 2020 - Yahoo Finance
finance.yahoo.com - October 22 at 3:44 PM
Jefferies Assumes Compugen (CGEN) at Buy (Earlier) - StreetInsider.comJefferies Assumes Compugen (CGEN) at Buy (Earlier) - StreetInsider.com
streetinsider.com - October 14 at 2:30 PM
Compugen Announces Addition of Immuno-oncology Pioneer Dr. Nils Lonberg to its Scientific Advisory Board - PRNewswireCompugen Announces Addition of Immuno-oncology Pioneer Dr. Nils Lonberg to its Scientific Advisory Board - PRNewswire
prnewswire.com - September 30 at 8:11 AM
Our Take On Compugens (NASDAQ:CGEN) CEO Salary - Yahoo FinanceOur Take On Compugen's (NASDAQ:CGEN) CEO Salary - Yahoo Finance
finance.yahoo.com - September 12 at 1:45 PM
Our Take On Compugen's (NASDAQ:CGEN) CEO SalaryOur Take On Compugen's (NASDAQ:CGEN) CEO Salary
finance.yahoo.com - September 12 at 1:45 PM
Compugen Starts Dosing In Early-Stage Combination Study For Solid Tumors - Yahoo FinanceCompugen Starts Dosing In Early-Stage Combination Study For Solid Tumors - Yahoo Finance
finance.yahoo.com - September 9 at 3:23 PM
Compugen Starts Dosing In Early-Stage Combination Study For Solid TumorsCompugen Starts Dosing In Early-Stage Combination Study For Solid Tumors
finance.yahoo.com - September 9 at 9:59 AM
Compugen Doses First Patient in Phase 1/2 Triple Combination Study of COM701 with Bristol Myers Squibbs Opdivo® and Anti-TIGIT Antibody - PRNewswireCompugen Doses First Patient in Phase 1/2 Triple Combination Study of COM701 with Bristol Myers Squibb's Opdivo® and Anti-TIGIT Antibody - PRNewswire
prnewswire.com - September 9 at 4:16 AM
Form 6-K COMPUGEN LTD For: Sep 08 - StreetInsider.comForm 6-K COMPUGEN LTD For: Sep 08 - StreetInsider.com
streetinsider.com - September 8 at 11:16 PM
Compugen launches early-stage combination study for COM701 in solid tumorsCompugen launches early-stage combination study for COM701 in solid tumors
seekingalpha.com - September 8 at 6:15 PM
Compugen Doses First Patient in Phase 1/2 Triple Combination Study of COM701 with Bristol Myers Squibb's Opdivo® and Anti-TIGIT AntibodyCompugen Doses First Patient in Phase 1/2 Triple Combination Study of COM701 with Bristol Myers Squibb's Opdivo® and Anti-TIGIT Antibody
finance.yahoo.com - September 8 at 8:08 AM
Compugen to Present at Upcoming September 2020 Investor Conferences - PRNewswireCompugen to Present at Upcoming September 2020 Investor Conferences - PRNewswire
prnewswire.com - September 3 at 8:54 AM
Compugen nabs new U.S. patent for COM902Compugen nabs new U.S. patent for COM902
seekingalpha.com - August 29 at 10:02 AM
Compugen Expands Patent Portfolio for TIGIT Inhibitor COM902 with New US Composition of Matter Patent - PRNewswireCompugen Expands Patent Portfolio for TIGIT Inhibitor COM902 with New US Composition of Matter Patent - PRNewswire
prnewswire.com - August 28 at 8:18 AM
Compugen Expands Patent Portfolio for TIGIT Inhibitor COM902 with New US Composition of Matter PatentCompugen Expands Patent Portfolio for TIGIT Inhibitor COM902 with New US Composition of Matter Patent
prnewswire.com - August 28 at 7:24 AM
4 Biotech Stocks Under $20 Analysts Love4 Biotech Stocks Under $20 Analysts Love
stocknews.com - August 18 at 5:30 PM
Form 6-K COMPUGEN LTD For: Aug 05 - StreetInsider.comForm 6-K COMPUGEN LTD For: Aug 05 - StreetInsider.com
streetinsider.com - August 5 at 11:36 PM
Compugen Ltd (CGEN) CEO Anat Dayag on Q2 2020 Results - Earnings Call Transcript - Seeking AlphaCompugen Ltd (CGEN) CEO Anat Dayag on Q2 2020 Results - Earnings Call Transcript - Seeking Alpha
seekingalpha.com - July 31 at 1:30 PM
Compugen Ltd. (CGEN) Q2 2020 Earnings Call Transcript - NasdaqCompugen Ltd. (CGEN) Q2 2020 Earnings Call Transcript - Nasdaq
www.nasdaq.com - July 31 at 8:29 AM
Compugen Ltd. (CGEN) Q2 2020 Earnings Call Transcript - Motley FoolCompugen Ltd. (CGEN) Q2 2020 Earnings Call Transcript - Motley Fool
www.fool.com - July 31 at 3:29 AM
Compugen Ltd. (CGEN) Q2 2020 Earnings Call TranscriptCompugen Ltd. (CGEN) Q2 2020 Earnings Call Transcript
finance.yahoo.com - July 31 at 3:29 AM
Compugen (CGEN) Tops Q2 EPS by 2c - StreetInsider.comCompugen (CGEN) Tops Q2 EPS by 2c - StreetInsider.com
www.streetinsider.com - July 30 at 12:27 PM
Compugen Reports Second Quarter 2020 Results English English - PRNewswireCompugen Reports Second Quarter 2020 Results English English - PRNewswire
www.prnewswire.com - July 30 at 7:26 AM
Compugen: Clinical Data Supports COM701 As A Potential Breakthrough Cancer Treatment - Seeking AlphaCompugen: Clinical Data Supports COM701 As A Potential Breakthrough Cancer Treatment - Seeking Alpha
seekingalpha.com - July 27 at 12:24 PM
Compugen to Release Second Quarter 2020 Results on Thursday, July 30, 2020 - Yahoo FinanceCompugen to Release Second Quarter 2020 Results on Thursday, July 30, 2020 - Yahoo Finance
finance.yahoo.com - July 16 at 8:21 AM
Are Institutions Heavily Invested In Compugen Ltd.'s (NASDAQ:CGEN) Shares?Are Institutions Heavily Invested In Compugen Ltd.'s (NASDAQ:CGEN) Shares?
finance.yahoo.com - July 14 at 6:47 PM
Hedge Funds Have Never Been This Bullish On Compugen Ltd. (CGEN) - Yahoo FinanceHedge Funds Have Never Been This Bullish On Compugen Ltd. (CGEN) - Yahoo Finance
finance.yahoo.com - June 22 at 7:47 PM
Hedge Funds Have Never Been This Bullish On Compugen Ltd. (CGEN)Hedge Funds Have Never Been This Bullish On Compugen Ltd. (CGEN)
finance.yahoo.com - June 22 at 2:47 PM
This page was last updated on 12/4/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.